Chemotherapy is generally a total of 6 sessions. And Friday, 10/30, is the day to check the effectiveness after the 3rd ...
Chemotherapy is a powerful cancer medication—but it can also be a very challenging treatment. It works by killing fast-growing cancer cells but kills healthy cells too, so it's important to know how ...
Laura Stanford is told she cannot have Enhertu as she is on her third round of chemotherapy.
A clinical trial will test zanubrutinib plus sonrotoclax as a fixed-duration, chemotherapy-free treatment for hairy cell ...
A prospective Hungarian study of 50 breast cancer patients found the PAXMAN scalp cooling system preserved hair in 69% of ...
Some people with rectal cancer may now be able to skip chemotherapy, radiation and surgery. The U.S. Food and Drug ...
Amivantamab plus chemotherapy demonstrates durable benefit with a differentiated approach that dual targets EGFR and MET1Median overall survival reached 34.3 months with the amivantamab-based regimen, ...
A user-centered study from Zunyi Medical University reports that a WeChat-embedded platform for monitoring ...
Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS) Adult ...
Women with advanced or recurrent mismatch repair deficient (dMMR) endometrial cancer who were treated with immunotherapy alone lived longer without their cancer progressing than women treated with ...
BlackRock ETF Trust II - iShares Flexible Income Active ETF's filing packet contains an announcement from GSK plc regarding positive results from its ARTEMIS-011 study. The pivotal phase III trial in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results